General Electric (NYSE: GE) Beefs Up Healthcare Unit

GE Healthcare, the health care unit of General Electric (NYSE: GE) announced that it will purchase Clarient Inc, an industry leader in molecular diagnostics. The purchase is expected to help develop new tools for the diagnosis and imaging of cancer. The deal will allow GE to buy Clarient at $5.00 per share payable in cash.